Login
Toggle navigation
Videos
Categories
Trending
Belgian CEO Showdown: June 5, 2023 | Raymund Trost - CEO of CFE
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Raymund Trost is the Président/CEO of CFE
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Neil Abramson on Mastering Collective Bargaining | Neil H. Abramson - Partner, Proskauer Rose LLP
00:10:00
Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd
00:10:00
San Jose Lithium Project: Key Insights and Strategic Partnerships
00:10:00
When Financial Rules of Thumb Work and When They Don't | Doug Lockwood - WEALTH MANAGER at Credent Wealth Management
00:10:00
Legendary Investor Bill Wilby's Timeless Retirement Strategy: Insights from WEALTHTRACK
00:10:00
ALT moves forward to expand Thairath internet gateway exchange platform | Preeyapun Bhuwakul, Executive Director, ALT Telecom PCLALT:SET
00:10:00
Northwest Fund: Stable Returns with 9% Note Rate and Predictable Performance
00:10:00
Coret Task Force on K-12 Education: 16 Years of Policy Influence and Future Directions|Chester E. Finn Jr.
00:10:00
CapMan's Strategic Updates and Ambitious Growth Targets Discussed by CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
Mineral Exploration: Navigating the Future - Insights from Ken Witherly | Ken Witherly , President of Condor Consulting Inc.
00:10:00
Seeks total return | Christopher Kelliher,Fund Manager,Fidelity Advisor Risk Parity Fund
00:10:00
Driving Progress: A Year of Achievements and Future Aspirations | Liv Garfield, CEO, Severn Trent Water SA.